1. The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer
    Alireza Andalib et al, 2020, Indian Journal of Clinical Biochemistry CrossRef

  2. CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1


    Yanling Lin et al, 2020, Cancer Management and Research CrossRef
  3. Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
    Jianying Guo et al, 2014, Oncotarget CrossRef
  4. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression
    Chiara Compagnoni et al, 2023, International Journal of Molecular Sciences CrossRef
  5. Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model
    Filippo Del Vecchio et al, 2015, BMC Bioinformatics CrossRef
  6. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
    Naoki Suenaga et al, 2019, International Journal of Molecular Sciences CrossRef
  7. Nuclear Expression of the Deubiquitinase CYLD Is Associated with Improved Survival in Human Hepatocellular Carcinoma
    Stefan Welte et al, 2014, PLoS ONE CrossRef
  8. Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance
    Ayumi Kanemaru et al, 2022, Cancer Cell International CrossRef
  9. MiR-454 Prompts Cell Proliferation of Human Colorectal Cancer Cells by Repressing CYLD Expression
    Hong-Liang Liang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
  10. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice
    Josefa P. Alameda et al, 2021, International Journal of Molecular Sciences CrossRef
  11. LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas
    Kazuto Harada et al, 2015, Annals of Surgical Oncology CrossRef
  12. Ulcerating Tumor of the Scalp: Answer
    Stanislav N. Tolkachjov et al, 2017, The American Journal of Dermatopathology CrossRef
  13. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD
    Jaceline Gislaine Pires Sanches et al, 2018, Chemico-Biological Interactions CrossRef
  14. Copy number variation of ubiquitin- specific proteases genes in blood leukocytes and colorectal cancer
    Tian Tian et al, 2020, Cancer Biology & Therapy CrossRef
  15. Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma
    Shunsuke Miyake et al, 2020, PLOS ONE CrossRef
  16. The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
    Rin Liu et al, 2021, Cancers CrossRef
  17. Post-translational control of NF-κB signaling by ubiquitination
    Minho Won et al, 2016, Archives of Pharmacal Research CrossRef
  18. CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters
    Vasiliki Papadatou et al, 2022, Taiwanese Journal of Obstetrics and Gynecology CrossRef
  19. Clinical significance of cylindromatosis expression in primary hepatocellular carcinoma
    Si Ying Tang et al, 2023, Arab Journal of Gastroenterology CrossRef